Acorda Therapeutics Inc - Company & Market Research Reports

Acorda Therapeutics is a biopharmaceutical company that identifies, develops, and commercializes novel therapies for neurological disorders in the United States. It specializes in drugs that improve neurological function in people with multiple sclerosis, spinal cord injury and other disorders of the central nervous system. Its best known products are Zanaflex, Ampyra and Qutenza. Acorda Therapeutics was founded in 1995 and is headquartered in Ardsley, New York.

Global Neurodegenerative Drugs Market to 2022 - Growth Driven by an Aging Population, the Approval of Novel Immunomodulators and Neuromodulators, and Strong Uptake of Marketed Anti-Inflammatory Treatments - Product Thumbnail Image

Global Neurodegenerative Drugs Market to 2022 - Growth Driven by an Aging Population, the Approval of Novel Immunomodulators and Neuromodulators, and Strong Uptake of Marketed Anti-Inflammatory Treatments

  • Report
  • 133 Pages
From
Market Spotlight: Neuropathic Pain - Product Thumbnail Image

Market Spotlight: Neuropathic Pain

  • Report
  • 36 Pages
From
Global Multiple Sclerosis Drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 to 2025 - Product Thumbnail Image

Global Multiple Sclerosis Drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 to 2025

  • Report
From
CNS Therapeutics - Global Strategic Business Report - Product Thumbnail Image

CNS Therapeutics - Global Strategic Business Report

  • Report
  • 611 Pages
From
Diabetic Neuropathic Pain - Pipeline Review, H1 2015 - Product Thumbnail Image

Diabetic Neuropathic Pain - Pipeline Review, H1 2015

  • Report
  • 106 Pages
From
Parkinson's Disease Market: Pipeline Review, Developer Landscape and Competitive Insights - Product Thumbnail Image

Parkinson's Disease Market: Pipeline Review, Developer Landscape and Competitive Insights

  • Report
  • 204 Pages
From
Postherpetic Neuralgia Global Clinical Trials Review, H1, 2018 - Product Thumbnail Image

Postherpetic Neuralgia Global Clinical Trials Review, H1, 2018

  • Clinical Trials
  • 184 Pages
From
Cerebral Palsy Global Clinical Trials Review, H1, 2017 - Product Thumbnail Image

Cerebral Palsy Global Clinical Trials Review, H1, 2017

  • Clinical Trials
  • 113 Pages
From
Anti-Parkinson's Drugs: Global Markets to 2022 - Product Thumbnail Image

Anti-Parkinson's Drugs: Global Markets to 2022

  • Report
  • 172 Pages
From
Pain Drug Development Pipeline Review, 2017 - Product Thumbnail Image

Pain Drug Development Pipeline Review, 2017

  • Report
  • 229 Pages
From
Global Painful Diabetic Neuropathy Drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2018 To 2026 - Product Thumbnail Image

Global Painful Diabetic Neuropathy Drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2018 To 2026

  • Report
From
Parkinson's: Disease Inights and Market Forecasts to 2024 - Product Thumbnail Image

Parkinson's: Disease Inights and Market Forecasts to 2024

  • Report
  • 120 Pages
From
Parkinson's: Epidemiology Overview and Insights - Product Thumbnail Image

Parkinson's: Epidemiology Overview and Insights

  • Report
  • 50 Pages
From
Global Multiple Sclerosis Market Research and Forecast 2018-2023 - Product Thumbnail Image

Global Multiple Sclerosis Market Research and Forecast 2018-2023

  • Report
From
Dry Powder Inhaler Devices - Medical Devices Pipeline Assessment, 2018 - Product Thumbnail Image

Dry Powder Inhaler Devices - Medical Devices Pipeline Assessment, 2018

  • Report
  • 238 Pages
From
Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies - Product Thumbnail Image

Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies

  • Report
  • 385 Pages
From
Global Epilepsy Drugs Market 2016-2020 - Product Thumbnail Image

Global Epilepsy Drugs Market 2016-2020

  • Report
  • 87 Pages
From
Global Botulinum Toxin Market 2017-2021 - Product Thumbnail Image

Global Botulinum Toxin Market 2017-2021

  • Report
  • 70 Pages
From
Global Central Nervous System Disorders Therapeutics Market 2016-2020 - Product Thumbnail Image

Global Central Nervous System Disorders Therapeutics Market 2016-2020

  • Report
  • 147 Pages
From
Parkinson's Disease Therapeutics in Major Developed Markets to 2021: Early Pipeline Shifts Towards Disease-Modifying Therapies, while Short Term Growth Driven by Long-Acting Symptomatic Treatments - Product Thumbnail Image

Parkinson's Disease Therapeutics in Major Developed Markets to 2021: Early Pipeline Shifts Towards Disease-Modifying Therapies, while Short Term Growth Driven by Long-Acting Symptomatic Treatments

  • Report
  • 136 Pages
From
Loading Indicator
adroll